Treatment of malignant gliomas with TGF-beta2 antisense oligonucleotides.
about
Oligonucleotide therapeutic approaches for Huntington diseaseTGF-β signaling and its targeting for glioma treatmentMicroarray-based transcriptional and epigenetic profiling of matrix metalloproteinases, collagens, and related genes in cancer.Experimental approaches for the treatment of malignant gliomas.Restoring dystrophin expression in duchenne muscular dystrophy muscle progress in exon skipping and stop codon read through.Recent developments on immunotherapy for brain cancer.Target mRNA inhibition by oligonucleotide drugs in man.Improving cancer immunotherapy by targeting tumor-induced immune suppression.Exploring anti-TGF-β therapies in cancer and fibrosis.Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach.A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy.Vectors and strategies for nonviral cancer gene therapy.Targeting TGF-β Signaling for Therapeutic Gain.Nucleic acids in human glioma treatment: innovative approaches and recent resultsDesulfurization of phosphorothioate oligonucleotides via the sulfur-by-oxygen replacement induced by the hydroxyl radical during negative electrospray ionization mass spectrometry.Efficient in vivo microRNA targeting of liver metastasis.Potential role of miRNAs and their inhibitors in glioma treatment.
P2860
Q22306293-1A45DCC1-0739-4F94-8F9C-8B5E3520FA3CQ28082042-C805C385-9C09-4659-BEA4-E150DCE117C1Q33911466-76AA0306-7E58-4A13-BEC9-3D0A8CF1AEC3Q34127138-FAAEE4EB-698C-4C1B-AB9B-D6B16FBCCC45Q35072755-88EF1AEE-E22B-4B38-B854-184430BE8CCAQ35992355-7B52C438-CD46-41F7-B587-1717B5578E3BQ36435109-2F3AEAFB-1312-4F54-B5ED-0F5C438306D9Q37830362-5F86C36E-B576-43C8-80BA-4EDFA301AA8CQ37896073-1F0A446C-9BD0-4634-86C3-FF7E10150287Q38108186-817DA398-B129-4BA0-8EDF-8BB589E26AB2Q38227889-56303D82-D778-4849-BD43-AB43ACBA9146Q38694798-4223303B-058F-4132-A13A-C2FD4FF68E2CQ39155151-812D6884-FCBC-484C-BDD6-5929E4E63F91Q42111511-98326066-37FF-4DFF-9BDF-63B537D6EF0DQ44365925-B070805A-986D-4AFE-AF16-55C5A1A8D5D6Q46584676-7B631CBF-1C43-4EF8-8FB4-1373C1117883Q55463671-97C63B5A-8463-4B96-8A91-AEDBF0453253
P2860
Treatment of malignant gliomas with TGF-beta2 antisense oligonucleotides.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Treatment of malignant gliomas with TGF-beta2 antisense oligonucleotides.
@en
Treatment of malignant gliomas with TGF-beta2 antisense oligonucleotides.
@nl
type
label
Treatment of malignant gliomas with TGF-beta2 antisense oligonucleotides.
@en
Treatment of malignant gliomas with TGF-beta2 antisense oligonucleotides.
@nl
prefLabel
Treatment of malignant gliomas with TGF-beta2 antisense oligonucleotides.
@en
Treatment of malignant gliomas with TGF-beta2 antisense oligonucleotides.
@nl
P2860
P356
P1476
Treatment of malignant gliomas with TGF-beta2 antisense oligonucleotides.
@en
P2093
Piotr Jachimczak
P2860
P304
P356
10.1586/ERA.09.138
P577
2009-11-01T00:00:00Z